EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

Definition, Diagnosis, Risk Stratification and Management of Newly Diagnosed Multiple Myeloma: The Saudi Myeloma Working Group Guidelines

Ghazi S Alotaibi, Abdullah S Al Saleh, Ayman Alhejazi, Majed Alahmadi, Ibraheem Motabi, Fahad Z Alsharif, Abdullah Alamer, Omar Abduljalil, Imran Tailor, Mohammed Marei, Ahmed S Barefah, Mansour Aljabry und 8 weitere

Clinical Lymphoma Myeloma and Leukemia · 2025

DOI: 10.1016/j.clml.2025.06.005 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2025. Verfasst von Ghazi S Alotaibi und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine (Oncology Center), College of Medicine, King Saud University, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Multiple Myeloma. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Scientific Research, King Saud University, Sanofi Saudi Arabia, Johnson and Johnson.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple myeloma is a rising concern globally, with increasing incidence and mortality, especially in low- and middle-income countries. In Saudi Arabia, multiple myeloma care faces significant challenges outside tertiary care centers, including delays in diagnosis, limited availability of standardized treatment protocols, and considerable disparities in healthcare infrastructure. These issues are particularly prominent in non-urban and secondary healthcare facilities, where access to specialized diagnostics and therapies may be restricted, impacting early detection and optimal management of the disease. Although treatment advances have improved survival rates, multiple myeloma remains incurable and poses significant financial burdens due to the high cost of therapies, particularly in resource-constrained settings. This updated guideline from the Saudi Myeloma Working Group aims to address the gaps in newly diagnosed multiple myeloma management in Saudi Arabia.xsy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaHumansSaudi ArabiaDisease ManagementRisk AssessmentPractice Guidelines as Topic

Stichwörter der Autor:innen

Plasma cell dyscrasiasSaudi Arabia

Autor:innen und Institutionen

  • Department of Medicine (Oncology Center), College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; Division of Hematology and HSCT, Department of Oncology, King Saud bin Abdulaziz University for Health Sciences, Riyadh,…
  • King Abdulaziz Medical City, Department of Oncology, Riyadh, Saudi Arabia.
  • Department of Adult Hematology/Bone Marrow Transplant Section, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, Jeddah, Saudi Arabia; College of Medicine, King Saud Bin Abdulaziz University for He…
  • Adult Hematology & Bone Marrow Transplant Department, Comprehensive Cancer Center at King Fahad Medical City, Riyadh, Saudi Arabia; Department of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
  • King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

Förderung

  • Deanship of Scientific Research, King Saud University
  • Sanofi Saudi Arabia
  • Johnson and Johnson
  • Johnson & Johnson Innovative Medicine

Zitieren

APA

Alotaibi, G. S., Saleh, A. S. A., Alhejazi, A., Alahmadi, M., Motabi, I., Alsharif, F. Z., Alamer, A., Abduljalil, O., Tailor, I., Marei, M., Barefah, A. S., Aljabry, M., Alhayli, S., Usman, B., Hanbali, A., Alabdulwahab, A., ElHemaidi, I., Alahwal, H. M., Mutahar, E., & Alsaeed, A. (2025). Definition, Diagnosis, Risk Stratification and Management of Newly Diagnosed Multiple Myeloma: The Saudi Myeloma Working Group Guidelines. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2025.06.005

Vancouver

Alotaibi GS, Saleh ASA, Alhejazi A, Alahmadi M, Motabi I, Alsharif FZ, et al. Definition, Diagnosis, Risk Stratification and Management of Newly Diagnosed Multiple Myeloma: The Saudi Myeloma Working Group Guidelines. Clinical Lymphoma Myeloma and Leukemia. 2025. doi:10.1016/j.clml.2025.06.005

BibTeX
@article{Alotaibi2025,
  author = {Alotaibi, Ghazi S and Saleh, Abdullah S Al and Alhejazi, Ayman and Alahmadi, Majed and Motabi, Ibraheem and Alsharif, Fahad Z and Alamer, Abdullah and Abduljalil, Omar and Tailor, Imran and Marei, Mohammed and Barefah, Ahmed S and Aljabry, Mansour and Alhayli, Saud and Usman, Binyam and Hanbali, Amr and Alabdulwahab, Amal and ElHemaidi, Ihab and Alahwal, Hatem Mahmoud and Mutahar, Enas and Alsaeed, Ahmad},
  title = {Definition, Diagnosis, Risk Stratification and Management of Newly Diagnosed Multiple Myeloma: The Saudi Myeloma Working Group Guidelines},
  journal = {Clinical Lymphoma Myeloma and Leukemia},
  year = {2025},
  doi = {10.1016/j.clml.2025.06.005}
}
Kostenlos starten →